Drug Patents owned by Organon Sub Merck

1. List of Bridion drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
USRE44733 ORGANON SUB MERCK 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
Jan, 2026

(2 years from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) Jun 25, 2024
M (M) Jun 9, 2023

Drugs and Companies using SUGAMMADEX SODIUM ingredient

Market Authorisation Date: 15 December, 2015

Treatment: Reversal of drug-induced neuromuscular block


How can I launch a generic of BRIDION before it's patent expiration?
More Information on Dosage

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic